Ruxolitinib mitigates steroid-refractory CRS during CAR T therapy.

Pan J, Deng B, Ling Z, Song W, Xu J, Duan J, Wang Z, Chang AH, Feng X, Tan Y
J Cell Mol Med. 2021 Jan;25(2):1089-1099. doi: 10.1111/jcmm.16176. Epub 2020 Dec 12. PubMed Article

Plasmids from Article

No plasmids are currently publicly available from Addgene for this article.